Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
46 hedge funds and large institutions have $17.1M invested in Ocean Biomedical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 5 closing their positions.
459% more capital invested
Capital invested by funds: $3.06M → $17.1M (+$14.1M)
259% more call options, than puts
Call options by funds: $2.31M | Put options by funds: $645K
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
31% more funds holding
Funds holding: 35 → 46 (+11)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$461K |
| 2 |
BlackRock
New York
|
+$347K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$223K |
| 4 |
LPL Financial
San Diego,
California
|
+$56.4K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$44.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$375K |
| 2 |
Morgan Stanley
New York
|
-$107K |
| 3 |
Mariner
Overland Park,
Kansas
|
-$29.3K |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$21.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$209 | +111 | New |
|
OCEA Hedge Fund Activity: Q1 2024 in Review
46 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2024, worth a combined $17.1M — up 459% from $3.06M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new OCEA positions and 5 closed out — a net gain of 11 holders — while 7 added to existing stakes and 16 trimmed.
The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $461K. The largest seller was Meteora Capital, exiting entirely with an estimated $375K sold.
- 46 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2024, up from 35 in Q4 2023.
- Funds reported $17.1M of Ocean Biomedical, Inc. Common Stock stock for Q1 2024, up 459% quarter-over-quarter.
- 16 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2024 and 5 closed out, a net change of +11 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2024 was OMERS Administration Corp, an estimated $461K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2024 was Meteora Capital, an estimated $375K sold.
Based on aggregated 13F filings for Q1 2024.